Abstract
BACKGROUND: Ectopic pregnancy is the leading cause of first-trimester maternal death, accounting for 9% of pregnancy-related deaths. Interstitial (cornual) pregnancies represent 6% of all ectopics but account for a disproportionately higher mortality rate. Surgical management has been the treatment of choice for interstitial pregnancies. A very limited number of articles have explored the use of intravenous methotrexate to treat cornual pregnancy as a possible conservative first-line therapy in selected, hemodynamically stable patients. CASE: A patient with a confirmed interstitial pregnancy was treated with intravenous methotrexate. The patient's β-hCG levels decreased to zero within 9 weeks. CONCLUSION: Intravenous methotrexate was used successfully in the treatment of an interstitual pregnancy without complications.
| Original language | American English |
|---|---|
| Pages (from-to) | 121-122 |
| Number of pages | 2 |
| Journal | Journal of Reproductive Medicine for the Obstetrician and Gynecologist |
| Volume | 49 |
| Issue number | 2 |
| State | Published - Feb 2004 |
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynecology
Keywords
- Methotrexate
- Pregancy, ectopic